Intragam P (CSL Ltd)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIntragam P (CSL Ltd)
Drug Alias NameImmunoglobulin therapy (primary immunodeficiency)Intragam
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsImmunologic Deficiency Syndromes
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2008/02/01
Country/TerritorySingaporeNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCsl Ltd
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A